Inhibition of BMI-1 Induces Apoptosis through Downregulation of DUB3-Mediated Mcl-1 Stabilization.
Kaixin WuSeon-Min WooSeung-Un SeoTaeg-Kyu KwonPublished in: International journal of molecular sciences (2021)
BMI-1, a polycomb ring finger oncogene, is highly expressed in multiple cancer cells and is involved in cancer cell proliferation, invasion, and apoptosis. BMI-1 represents a cancer stemness marker that is associated with the regulation of stem cell self-renewal. In this study, pharmacological inhibition (PTC596) or knockdown (siRNA) of BMI-1 reduced cancer stem-like cells and enhanced cancer cell death. Mechanistically, the inhibition of BMI-1 induced the downregulation of Mcl-1 protein, but not Mcl-1 mRNA. PTC596 downregulated Mcl-1 protein expression at the post-translational level through the proteasome-ubiquitin system. PTC596 and BMI-1 siRNA induced downregulation of DUB3 deubiquitinase, which was strongly linked to Mcl-1 destabilization. Furthermore, overexpression of Mcl-1 or DUB3 inhibited apoptosis by PTC596. Taken together, our findings reveal that the inhibition of BMI-1 induces Mcl-1 destabilization through downregulation of DUB3, resulting in the induction of cancer cell death.
Keyphrases
- cell proliferation
- cell death
- papillary thyroid
- body mass index
- stem cells
- squamous cell
- weight gain
- signaling pathway
- oxidative stress
- squamous cell carcinoma
- cell cycle
- endoplasmic reticulum stress
- childhood cancer
- young adults
- small molecule
- single cell
- endothelial cells
- cell therapy
- amino acid
- binding protein
- cell migration